Wang, R.-K., Wang, C.-E., Fei, Y.-Y., Gai, J.-Y
Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ Jr, Feduska NJ, Salvatierra O Jr
Important safety considerations : If you're taking insulin or sulfonylureas alongside GLP-1 therapy, discuss dose adjustments with your healthcare team to reduce hypoglycaemia risk GLP-1 medications are not recommended during pregnancy or breastfeeding
Financial Times reported this week that Lilly and Novo, the manufacturers of all four GLP-1 drugs commonly used for obesity therapy, are spending $3.5 billion this year to purchase smaller companies with promising anti-obesity therapies
Lipotropic injections are formulated with compounds that assist in the breakdown of fat during metabolism
We cover it in depth in our Retatrutide research guide, including the trial readouts and how the triple-agonist mechanism is thought to work